Active	Status	Sponsor type	Region	Phase	Filter
1 Active 0 Inactive 1 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other Show only owner-sponsored trials	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
AC676 / Accutar Biotech
NCT05780034: A Study of AC676 for the Treatment of Relapsed/Refractory B-Cell Malignancies	Recruiting	1	60	US	AC676	Accutar Biotechnology Inc	Relapsed/Refractory B-cell Malignancies	07/25	12/25